ZenYGrammatikopoulosTHadzicN.Autoimmune pancreatitis in children: insights into the diagnostic challenge. J Pediatr Gastroenterol Nutr. 2014;59:e42-e45.
2.
GallowayDPWallihanDSmithMTAbu-El-HaijaM.An unusual presentation of pediatric autoimmune pancreatitis. Pancreas. 2016;45:e1-e2.
3.
HasosahMYMasawaLJanAAlsaleemK.A case report of childhood recurrent autoimmune pancreatitis: a rare emerging entity. J Clin Diagnostic Res. 2016;10:SD01-SD02.
OkazakiKUchidaKFukuiTMatsushitaMTakaokaM.Recent advances in autoimmune pancreatitis. Gastroenterol Hepatol (N Y). 2008;4:417-426.
6.
ChariSTKloeppelGZhangLNotoharaKLerchMMShimosegawaT.Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreatology. 2010;10:664-672.
7.
RainaAYadavDKrasinskasAMet al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009;104:2295-2306.
8.
ShimosegawaTChariSTFrulloniLet al; International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352-358.
9.
HartPAKamisawaTBruggeWRet al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut. 2013;62:1771-1776.
10.
MaireRLe BaleurYReboursVet al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol. 2011;106:151-156.
11.
PerezEAGutierrezJCKoniarisLGNevilleHLThompsonWRSolaJE.Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients. J Pediatr Surg. 2009;44:197-203.
SahRPChariSTPannalaRet al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology. 2010;139:140-148.
14.
SandanayakeNSChurchNIChapmanMHet al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2009;7:1089-1096.
